Elanco Animal Health (ELAN) Tops Q3 EPS by 2c, Offers Guidance

Elanco Animal Health (NYSE: ELAN) reported Q3 EPS of $0.19, $0.02 better than the analyst estimate of $0.17. Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.08 billion.

GUIDANCE:

Elanco Animal Health sees Q4 2021 EPS of $0.13-$0.19, versus the consensus of $0.19. Elanco Animal Health sees Q4 2021 revenue of $1.08-1.12 billion, versus the consensus of $1.12 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c